Skip to main content
Signal8

Wilson Marc

SEC insider (Form 3/4/5 filer). CIK 0001702265. CFO at Crinetics Pharmaceuticals, Inc. (CRNX). 3 reported Form 4/5 transactions since Sep 2024; latest on Nov 20, 2024. Located in SAN DIEGO, CA.

Companies Wilson Marc has filed insider reports for

  • Crinetics Pharmaceuticals, Inc. (CRNX): Officer, CFO
Wilson Marc profile photo

Wilson Marc

CIK: 0001702265

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Crinetics Pharmaceuticals, Inc. logo
CRNX

Crinetics Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Crinetics Pharmaceuticals, Inc. logo
    CRNX

    Crinetics Pharmaceuticals, Inc.

    Nov 20, 2024
    Other
    Direct
    473 shares at avg. $14.98$7K
  • Crinetics Pharmaceuticals, Inc. logo
    CRNX

    Crinetics Pharmaceuticals, Inc.

    Sep 26, 2024
    Exercise
    Direct
    25K shares at avg. $15.29$382K
  • Crinetics Pharmaceuticals, Inc. logo
    CRNX

    Crinetics Pharmaceuticals, Inc.

    Sep 26, 2024
    Sale
    Direct
    25K shares at avg. $51.11$1.3M

1-3 of 3